
Michael P. Woodward
Examiner (ID: 16955)
| Most Active Art Unit | 1813 |
| Art Unit(s) | 1815, 1654, 1615, 1813, 1631, 1807, 1643, 1637 |
| Total Applications | 360 |
| Issued Applications | 165 |
| Pending Applications | 32 |
| Abandoned Applications | 163 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1165648
[patent_doc_number] => 06763087
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-07-13
[patent_title] => 'Mobile VDSL signal detector'
[patent_app_type] => B2
[patent_app_number] => 10/095968
[patent_app_country] => US
[patent_app_date] => 2002-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3179
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 209
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/763/06763087.pdf
[firstpage_image] =>[orig_patent_app_number] => 10095968
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/095968 | Mobile VDSL signal detector | Mar 12, 2002 | Issued |
| 09/959203 | Composition for semi-permanent skin coloration | Oct 21, 2001 | Abandoned |
| 09/962920 | Molecules specific for NPFF Receptors and uses thereof | Sep 23, 2001 | Abandoned |
Array
(
[id] => 6838443
[patent_doc_number] => 20030035783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-20
[patent_title] => 'Cosmetic agent in the form of a gel'
[patent_app_type] => new
[patent_app_number] => 10/018933
[patent_app_country] => US
[patent_app_date] => 2001-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4028
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20030035783.pdf
[firstpage_image] =>[orig_patent_app_number] => 10018933
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/018933 | Cosmetic agent in the form of a gel | Apr 6, 2001 | Issued |
Array
(
[id] => 4420775
[patent_doc_number] => 06194601
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-27
[patent_title] => '5,6-dihydronaphthalenyl derivatives having retinoid-like activity'
[patent_app_type] => 1
[patent_app_number] => 9/397975
[patent_app_country] => US
[patent_app_date] => 1999-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 11443
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/194/06194601.pdf
[firstpage_image] =>[orig_patent_app_number] => 397975
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/397975 | 5,6-dihydronaphthalenyl derivatives having retinoid-like activity | Sep 15, 1999 | Issued |
Array
(
[id] => 4131613
[patent_doc_number] => 06034056
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-07
[patent_title] => 'Fibronectin adhesion inhibitors'
[patent_app_type] => 1
[patent_app_number] => 8/860248
[patent_app_country] => US
[patent_app_date] => 1997-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 16
[patent_no_of_words] => 30494
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/034/06034056.pdf
[firstpage_image] =>[orig_patent_app_number] => 860248
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/860248 | Fibronectin adhesion inhibitors | Jun 23, 1997 | Issued |
Array
(
[id] => 3756863
[patent_doc_number] => 05741495
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-21
[patent_title] => 'Glucan drug delivery system and adjuvant'
[patent_app_type] => 1
[patent_app_number] => 8/810947
[patent_app_country] => US
[patent_app_date] => 1997-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4179
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/741/05741495.pdf
[firstpage_image] =>[orig_patent_app_number] => 810947
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/810947 | Glucan drug delivery system and adjuvant | Feb 26, 1997 | Issued |
Array
(
[id] => 3837689
[patent_doc_number] => 05846934
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-08
[patent_title] => 'Pure somatostatin antagonist and methods of use thereof'
[patent_app_type] => 1
[patent_app_number] => 8/801374
[patent_app_country] => US
[patent_app_date] => 1997-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5524
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/846/05846934.pdf
[firstpage_image] =>[orig_patent_app_number] => 801374
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/801374 | Pure somatostatin antagonist and methods of use thereof | Feb 18, 1997 | Issued |
Array
(
[id] => 1283110
[patent_doc_number] => 06638552
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-10-28
[patent_title] => 'Glutenin genes and their uses'
[patent_app_type] => B1
[patent_app_number] => 08/785716
[patent_app_country] => US
[patent_app_date] => 1997-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7607
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/638/06638552.pdf
[firstpage_image] =>[orig_patent_app_number] => 08785716
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/785716 | Glutenin genes and their uses | Jan 15, 1997 | Issued |
Array
(
[id] => 3770547
[patent_doc_number] => 05807695
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-15
[patent_title] => 'Metallic cation binding polypeptides and methods therefor'
[patent_app_type] => 1
[patent_app_number] => 8/773688
[patent_app_country] => US
[patent_app_date] => 1996-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14302
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/807/05807695.pdf
[firstpage_image] =>[orig_patent_app_number] => 773688
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/773688 | Metallic cation binding polypeptides and methods therefor | Dec 26, 1996 | Issued |
Array
(
[id] => 3828924
[patent_doc_number] => 05814321
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-29
[patent_title] => 'Oil adjuvant vaccine and method for preparing same'
[patent_app_type] => 1
[patent_app_number] => 8/758374
[patent_app_country] => US
[patent_app_date] => 1996-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15933
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/814/05814321.pdf
[firstpage_image] =>[orig_patent_app_number] => 758374
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/758374 | Oil adjuvant vaccine and method for preparing same | Nov 28, 1996 | Issued |
Array
(
[id] => 3741192
[patent_doc_number] => 05800982
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-01
[patent_title] => 'Antigenic peptides for growing hepatitis C virus, kit comprising the same and methods for its grouping using the same'
[patent_app_type] => 1
[patent_app_number] => 8/685764
[patent_app_country] => US
[patent_app_date] => 1996-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14703
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/800/05800982.pdf
[firstpage_image] =>[orig_patent_app_number] => 685764
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/685764 | Antigenic peptides for growing hepatitis C virus, kit comprising the same and methods for its grouping using the same | Jul 23, 1996 | Issued |
Array
(
[id] => 4019972
[patent_doc_number] => 05907033
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-05-25
[patent_title] => 'Anti-oncostatin M monoclonal antibodies'
[patent_app_type] => 1
[patent_app_number] => 8/678922
[patent_app_country] => US
[patent_app_date] => 1996-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 8219
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/907/05907033.pdf
[firstpage_image] =>[orig_patent_app_number] => 678922
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/678922 | Anti-oncostatin M monoclonal antibodies | Jul 11, 1996 | Issued |
Array
(
[id] => 3875055
[patent_doc_number] => 05824708
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-20
[patent_title] => 'Virucidal substances'
[patent_app_type] => 1
[patent_app_number] => 8/649714
[patent_app_country] => US
[patent_app_date] => 1996-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2600
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/824/05824708.pdf
[firstpage_image] =>[orig_patent_app_number] => 649714
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/649714 | Virucidal substances | Jun 26, 1996 | Issued |
| 08/579088 | MOUSE MONOCLONAL ANTIBODY (5-21-3) TO HUMAN IMMUNODEFICIENCY VIRUS GP41 PROTEIN | Dec 26, 1995 | Abandoned |
Array
(
[id] => 3789798
[patent_doc_number] => 05840855
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-24
[patent_title] => 'Mycobacterial recombinants and peptides'
[patent_app_type] => 1
[patent_app_number] => 8/577980
[patent_app_country] => US
[patent_app_date] => 1995-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 24953
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/840/05840855.pdf
[firstpage_image] =>[orig_patent_app_number] => 577980
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/577980 | Mycobacterial recombinants and peptides | Dec 21, 1995 | Issued |
Array
(
[id] => 3655446
[patent_doc_number] => 05658746
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-19
[patent_title] => 'Cell surface receptor complementation'
[patent_app_type] => 1
[patent_app_number] => 8/552432
[patent_app_country] => US
[patent_app_date] => 1995-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 2634
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/658/05658746.pdf
[firstpage_image] =>[orig_patent_app_number] => 552432
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/552432 | Cell surface receptor complementation | Nov 2, 1995 | Issued |
Array
(
[id] => 4323809
[patent_doc_number] => RE037381
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-18
[patent_title] => 'Vaccine against hepatitis A virus'
[patent_app_type] => 2
[patent_app_number] => 8/673408
[patent_app_country] => US
[patent_app_date] => 1995-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 4763
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/037/RE037381.pdf
[firstpage_image] =>[orig_patent_app_number] => 673408
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/673408 | Vaccine against hepatitis A virus | Sep 5, 1995 | Issued |
| 08/487840 | METHOD OF MEDIATING INHIBITION OF FAS-LIGAND EXPRESSION THROUGH USE OF RETINOID COMPOUNDS | Jun 6, 1995 | Abandoned |
Array
(
[id] => 4398572
[patent_doc_number] => 06297355
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-02
[patent_title] => 'Polypeptides displaying HBV antigenicity or hbv antigen specificity'
[patent_app_type] => 1
[patent_app_number] => 8/472301
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11365
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/297/06297355.pdf
[firstpage_image] =>[orig_patent_app_number] => 472301
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/472301 | Polypeptides displaying HBV antigenicity or hbv antigen specificity | Jun 6, 1995 | Issued |